[{"Assets_0_Q3_USD":369024000.0,"CommonStockSharesOutstanding_0_Q3_shares":79369891.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-67666000.0,"NetIncomeLoss_1_Q3_USD":-23146000.0,"NetIncomeLoss_3_Q3_USD":-69037000.0,"StockholdersEquity_0_Q3_USD":157695000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":3063000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":12329000.0,"Ticker":"KDNY","CIK":"1435049","name":"ADURO BIOTECH, INC.","OfficialName":"Chinook Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"858364832.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181030"}]